Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Genprex, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 24 | 28 | +4 |
| Shares | 384.6K | 670.2K | +285.6K (+74.3%) |
| Value | $93.5K | $152.9K | +$59.4K (+63.5%) |
New holders (8)
Institutions that held Genprex, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 304,395 | $69.4K | 0.00% |
| Eqis Capital Management, Inc. | 16,580 | $3.78K | 0.00% |
| Citigroup Inc | 12,606 | $2.87K | 0.00% |
| Mount Yale Investment Advisors, LLC | 50 | $11 | 0.00% |
| FMR LLC | 38 | $9 | 0.00% |
| Raymond James Financial Inc | 5 | $1 | 0.00% |
| Global Retirement Partners, LLC | 5 | $1 | 0.00% |
| Capital Advisors, Ltd. LLC | 25 | $0 | 0.00% |
Sold out (4)
Institutions that held Genprex, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| HRT Financial LP | 46,720 | $11.0K |
| Corsair Capital Management, L.P. | 10,000 | $2.45K |
| IFP Advisors, Inc | 4,484 | $1.10K |
| Northwestern Mutual Wealth Management Co | 512 | $126 |